- Home
- BOLT vs MDAI Comparison
BOLT vs MDAI Comparison
Compare BOLT & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- MDAI
- Stock Information
- Founded
- BOLT 2015
- MDAI 2013
- Country
- BOLT United States
- MDAI United States
- Employees
- BOLT N/A
- MDAI N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- MDAI Medical/Dental Instruments
- Sector
- BOLT Health Care
- MDAI Health Care
- Exchange
- BOLT Nasdaq
- MDAI Nasdaq
- Market Cap
- BOLT 25.3M
- MDAI 23.8M
- IPO Year
- BOLT 2021
- MDAI N/A
- Fundamental
- Price
- BOLT $0.57
- MDAI $1.40
- Analyst Decision
- BOLT Hold
- MDAI Strong Buy
- Analyst Count
- BOLT 5
- MDAI 3
- Target Price
- BOLT $1.25
- MDAI $4.50
- AVG Volume (30 Days)
- BOLT 126.9K
- MDAI 267.2K
- Earning Date
- BOLT 11-12-2024
- MDAI 11-06-2024
- Dividend Yield
- BOLT N/A
- MDAI N/A
- EPS Growth
- BOLT N/A
- MDAI N/A
- EPS
- BOLT N/A
- MDAI N/A
- Revenue
- BOLT $9,779,000.00
- MDAI $27,264,000.00
- Revenue This Year
- BOLT $16.30
- MDAI $59.53
- Revenue Next Year
- BOLT N/A
- MDAI N/A
- P/E Ratio
- BOLT N/A
- MDAI N/A
- Revenue Growth
- BOLT 35.86
- MDAI 44.52
- 52 Week Low
- BOLT $0.55
- MDAI $0.82
- 52 Week High
- BOLT $1.56
- MDAI $3.72
- Technical
- Relative Strength Index (RSI)
- BOLT 29.99
- MDAI 52.36
- Support Level
- BOLT $0.63
- MDAI $1.24
- Resistance Level
- BOLT $0.69
- MDAI $1.50
- Average True Range (ATR)
- BOLT 0.03
- MDAI 0.12
- MACD
- BOLT -0.01
- MDAI -0.01
- Stochastic Oscillator
- BOLT 3.49
- MDAI 44.44
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.